• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    More On LABB.MX



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Genomma Lab Internacional SAB de CV (LABB.MX)

    17.74 Down 0.57(3.11%) Jun 24, 3:59PM EDT
    ProfileGet Profile for:
    Genomma Lab Internacional SAB de CV
    Edificio Samara
    Piso 2
    Mexico City, DF 01210
    Mexico - Map
    Phone: 52 55 5081 0000
    Website: http://www.genommalab.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:894

    Business Summary 

    Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells over-the-counter pharmaceutical products, generic drugs, and personal care products in Mexico and internationally. The company offers approximately 83 own brands covering various product categories, including anti-acne products, generic drugs, sexual protection and enhancement products, hemorrhoid treatments, varicose vein treatments, hair loss treatments, topical analgesics, antacids, topical antifungals, colitis treatments, anti stress treatments, soaps, multivitamins, shampoos, and flu treatments, as well as creams to enhance the appearance of scars. It also provides air transportation services. The company was founded in 1996 and is based in Mexico City, México.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Genomma Lab Internacional SAB de CV

    Key Executives 
    Mr. Máximo Juda ,
    Chief Exec. Officer
    Mr. Antonio Zamora Galland ,
    Chief Financial Officer and Exec. VP
    Mr. Oscar Villalobos Torres ,
    Vice-Pres of Fin. and Admin.
    Marco Sparvieri ,
    Exec. VP of Global Sales
    Elías Sidaoui Silva ,
    Director of HR
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in MXN.